ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With GA

ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With GA

Condition:   Age-related Macular Degeneration
Interventions:   Combination Product: Subcutaneous elamipretide through the elamipretide delivery system;   Combination Product: Subcutaneos placebo through the elamipretide delivery system
Sponsor:   Stealth BioTherapeutics Inc.
Recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 20, 2019Comments OffElamipretide | Evaluate | Pharmacokinetics | ReCLAIM2 | SafetyEfficacy | Study | Subjects
Comments